Back
Rapt Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
RAPT
Rapt Therapeutics, Inc.
Last Price:
$57.71
Seasonality Move:
-39.76%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.
Rapt Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.74 | Sell |
| 20-day SMA: | 56.55 | Buy |
| 50-day SMA: | 43.01 | Buy |
| 200-day SMA: | 23.03 | Buy |
| 8-day EMA: | 54.1 | Buy |
| 20-day EMA: | 38.53 | Buy |
| 50-day EMA: | 20.55 | Buy |
| 200-day EMA: | 6.01 | Buy |
Rapt Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.57 | Buy |
| Relative Strength Index (14 RSI): | 78.96 | Buy |
| Chaikin Money Flow: | -9881710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.88 - 62.12) | Buy |
| Bollinger Bands (100): | (24.96 - 46.88) | Buy |
Rapt Therapeutics, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rapt Therapeutics, Inc. Stock
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 57.72 while RAPT 8-day simple moving average is 57.74, which is a Sell signal.
-
The stock price of RAPT is 57.72 while Rapt Therapeutics, Inc. 20-day SMA is 56.55, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day simple moving average is 43.01 while RAPT share price is 57.72, making it a Buy technically.
-
RAPT stock price is 57.72 and Rapt Therapeutics, Inc. 200-day simple moving average is 23.03, creating a Buy signal.
RAPT Technical Analysis vs Fundamental Analysis
Sell
47
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy or a Sell?
-
Rapt Therapeutics, Inc. stock is rated a SellThe current Rapt Therapeutics, Inc. [RAPT] share price is $57.72. The Score for RAPT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Rapt Therapeutics, Inc. Stock Info
Market Cap:
954.6M
Price in USD:
57.72
Share Volume:
12.1M
Rapt Therapeutics, Inc. 52-Week Range
52-Week High:
57.86
52-Week Low:
5.67
Sell
47
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Rapt Therapeutics, Inc. Share Price Forecast
-
What is the Rapt Therapeutics, Inc. stock price today?The Rapt Therapeutics, Inc. stock price is 57.72 USD today.
-
Will RAPT stock go up or go down?Rapt Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rapt Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rapt Therapeutics, Inc. is overvalued.
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 57.72 while RAPT 8-day exponential moving average is 54.10, which is a Buy signal.
-
The stock price of RAPT is 57.72 while Rapt Therapeutics, Inc. 20-day EMA is 38.53, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day exponential moving average is 20.55 while RAPT share price is 57.72, making it a Buy technically.
-
RAPT stock price is 57.72 and Rapt Therapeutics, Inc. 200-day simple moving average is 6.01, creating a Buy signal.
Fundamental Analysis of Rapt Therapeutics, Inc.
Is Rapt Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $1.58 per share.
Technical Analysis of Rapt Therapeutics, Inc.
Should I short Rapt Therapeutics, Inc. stock?
-
RAPT Moving Average Covergence Divergence (MACD) indicator is 15.57, suggesting Rapt Therapeutics, Inc. is a Buy
-
Rapt Therapeutics, Inc. Relative Strength Index (RSI) is 78.96, which suggest Rapt Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Rapt Therapeutics, Inc. is (41.88 - 62.12), which suggest Rapt Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Rapt Therapeutics, Inc. is (24.96 - 46.88), which suggest Rapt Therapeutics, Inc. is a Buy
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.